Print Page  Close Window

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Up 1.90 (1.73%)
Intraday High$112.38
Intraday Low$109.31
Data as of 08/17/18 4:03 p.m. ET
Minimum 20 minute delay
Refresh quote
Headlines More >
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Aug. 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of record of Quest Diagnostics common stock on October 5, 2018. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived fr... 
Quest Diagnostics Earns Gold Status in American Heart Association's Workplace Health Achievement Index
SECAUCUS, N.J., Aug. 16, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it achieved gold status in the American Heart Association's 2018 Workplace Health Achievement Index, ranking the company's workplace health program among the best in the nation. The American Heart Association created the Index with its CEO Roundtable members, a leadership collaborative of more than ... 
New Quest Diagnostics Data Shows Lyme Disease Prevalence Increasing and is Now Present in New U.S. States
- Number of positive tests for Lyme disease increased significantly between 2016 and 2017. - Historically concentrated in Pennsylvania and New England states, Lyme disease has been detected in each of the 50 United States and the District of Columbia. - Outside of the northeastern U.S., California and Florida - states not historically associated with significant rates of Lyme disease - saw the largest absolute increases in positive Lyme disease test results. - Notable increases also obs... 
Quest Diagnostics Reports Second Quarter 2018 Financial Results
-- Second quarter revenues of $1.92 billion, up 3.0% from 2017 -- Second quarter reported diluted EPS of $1.57, up 14.4% from 2017 -- Second quarter adjusted diluted EPS excluding amortization of $1.75, up 20.5% from 2017 -- Narrows outlook for full year 2018 revenues and diluted EPS. Revenues now expected to be between $7.70 billion and $7.74 billion. Reported diluted EPS now expected to be between $5.50 and $5.64 and adjusted diluted EPS excluding amortization expense now expected to ... 
Upcoming EventsMore >
Quest Diagnostics at the Morgan Stanley 16th Annual Global Healthcare Conference
Contact Us:
Shawn Bevec
Vice President Investor Relations

Company Calendar
August 2018?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.